
Exemplary growth in Turkey
03. September 2008
In partnership with Diagno Grup, a distributor located in Istanbul, Ankara and Izmir, HORIBA ABX recorded sales growth in Turkey of 35% last year, with 50% of sales made up by reagents. The Turkish market has become the most dynamic European market due to a political drive to catch up with healthcare standards in other European countries.
In Turkey, HORIBA ABX mainly sells systems from the PENTRA 120 family for hospitals. Stéphane Rougale, Distributor Network Manager and Artin Sandalci, Director of Diagno Grup, consider that "a 20% market share has been achieved through double digit growth over the past four years, which has been sustained thanks to innovative financing solutions developed within the framework of a French-Turkish partnership".
Nachrichten Archiv:
News feed
Subscribe to our news feed:

